Zheng Hua Ren
Director/Board Member at Hangzhou Shangjian Biotechnology Co., Ltd.
Profile
Zheng Hua Ren has worked as a Director at Hangzhou Shangjian Biotechnology Co., Ltd.
and as a Partner at ADDOR Capital Management Co. Ltd.
Zheng Hua Ren active positions
| Companies | Position | Start |
|---|---|---|
ADDOR Capital Management Co. Ltd.
 ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Private Equity Investor | - |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ADDOR Capital Management Co. Ltd.
ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Finance |
Hangzhou Shangjian Biotechnology Co., Ltd.
Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Health Technology |
- Stock Market
- Insiders
- Zheng Hua Ren
